zika
viru
zikv
becom
global
public
health
emerg
due
rapidli
expand
rang
abil
caus
sever
congenit
defect
microcephali
howev
fdaapprov
therapi
vaccin
zikv
infect
screen
viral
entri
inhibitor
found
chloroquin
cq
commonli
use
antimalari
fdaapprov
drug
also
repurpos
pathogen
could
significantli
inhibit
zikv
infect
vitro
block
viru
intern
also
demonstr
cq
attenu
zikvassoci
morbid
mortal
mice
final
prove
cq
protect
fetal
mice
microcephali
caus
zikv
infect
methodolog
focus
previous
identifi
antivir
screen
effect
zikv
prove
rapid
effici
mean
discov
new
zikv
therapeut
select
drug
previous
fdaapprov
cq
also
improv
likelihood
may
quickli
reach
stage
clinic
test
use
public
zika
viru
zikv
singlestrand
rna
viru
primarili
transmit
mosquito
close
relat
dengu
viru
denv
anoth
member
flavivirida
famili
musso
gubler
first
identifi
rhesu
monkey
zika
forest
uganda
dick
et
al
human
case
later
report
africa
asia
zikv
strain
becam
classifi
belong
either
african
asian
lineag
haddow
et
al
sinc
human
infect
asian
lineag
zikv
south
pacif
america
gulland
report
associ
syndrom
gb
meningoenceph
ebiomedicin
j
u
r
n
l
h
e
p
g
e
w
w
w
e
b
e
c
n
e
c
congenit
microcephali
araujo
et
al
brasil
et
al
drigger
et
al
rasmussen
et
al
zikv
also
found
sexual
transmiss
dortenzio
et
al
infect
found
caus
male
infertil
suscept
mice
et
al
other
abl
develop
mous
model
zikv
infect
utero
could
lead
microcephali
cugola
et
al
li
et
al
miner
et
al
given
zikv
acquir
sexual
activ
even
asymptomat
zikv
carrier
hill
et
al
extens
rang
mosquito
vector
human
travel
viru
becom
global
threat
current
fdaapprov
drug
avail
prevent
treatment
zikv
infect
associ
risk
congenit
defect
although
vaccin
earli
trial
effect
zikv
prevent
develop
manufactur
rigor
timeconsum
process
antibodybas
therapi
shown
promis
mous
model
howev
drug
expens
limit
suppli
safeti
yet
valid
human
drug
repurpos
screen
shown
past
effici
approach
speed
drug
develop
given
prioriti
strategi
devis
new
emerg
virus
nabel
zerhouni
screen
led
discoveri
potenti
new
therapi
entamoeba
histolytica
infect
debnath
et
al
hepat
c
viru
hcv
infect
et
al
also
zikv
barrow
et
al
xu
et
al
ebola
viru
ebov
outbreak
west
africa
research
desper
find
cure
could
rapidli
reach
need
multipl
fdaapprov
drug
screen
possibl
repurpos
ebov
treatment
johansen
et
al
johansen
et
al
kouznetsova
et
al
decid
perform
similar
screen
ebov
inhibitor
potenti
use
zikv
drug
alreadi
pass
strict
fda
guidelin
human
safeti
candid
promis
efficaci
zikv
might
approv
rapidli
novel
drug
antizikv
therapi
note
found
one
drug
chloroquin
inhibit
zikv
infect
effici
vitro
agreement
previou
find
cq
could
inhibit
zikv
strain
brazilian
strain
infect
vero
human
brain
microvascular
endotheli
cell
hbmec
hnpc
cell
delvecchio
et
al
result
demonstr
cq
suppress
zikv
infect
mous
model
vivo
protect
embryon
brain
zikv
infect
associ
microcephali
mice
receptor
defici
gift
professor
qibin
leng
institut
pasteur
shanghai
chines
academi
scienc
china
icr
mice
bought
vital
river
laboratori
beij
china
balbc
kunm
mice
bought
jackson
laboratori
bar
harbor
bred
core
anim
facil
experi
relat
anim
conduct
accord
protocol
approv
anim
experi
committe
laboratori
anim
center
academi
militari
medic
scienc
china
zikv
strain
genbank
genbank
use
studi
describ
previou
work
zhang
et
al
vero
cell
bought
atcc
cultur
dmem
media
media
supplement
fb
excel
bio
jiangsu
unitsml
penicillin
streptomycin
provid
dr
peiyong
shi
novarti
institut
infecti
diseas
chloroquin
sigma
molecul
purchas
sigma
sangon
shanghai
china
total
rna
cell
supernat
extract
easypur
viral
dnarna
kit
transgen
biotech
beij
viral
rna
copi
detect
real
time
quantit
pcr
qrtpcr
johnson
et
al
zikv
primer
describ
previous
zikv
intern
assay
plaqu
assay
perform
describ
previous
talarico
et
al
briefli
cell
seed
well
plate
infect
zikv
pfu
h
cell
wash
pb
incub
h
allow
viru
intern
cell
wash
pb
treat
citric
acid
buffer
ph
inactiv
nonintern
virus
media
contain
fb
agar
immedi
ad
plaqu
assay
describ
previous
li
et
al
viral
plaqu
count
dpi
zikv
replicon
assay
conduct
describ
previous
liu
et
al
xie
et
al
briefli
vitro
transcrib
rna
transfect
lipofectamin
reagent
thermo
fisher
cell
seed
well
plate
hour
post
transfect
hpt
cq
ad
media
hpt
renilla
luciferas
activ
cell
lysat
measur
micropl
reader
promega
weekold
balbc
mice
femal
mice
treat
cq
control
intragastr
ig
h
zikv
infect
daili
follow
day
mice
mice
infect
intraperiton
ip
zikv
strain
zikv
rna
copi
serum
indic
time
point
measur
qrtpcr
describ
previous
li
et
al
neonat
mous
infect
dmem
contain
pfu
zikv
inject
intracerebr
kunm
mice
mgkg
cq
administr
sc
rout
mother
mice
previous
describ
keyaert
et
al
microcephali
model
zikv
viru
stock
pfuml
cultur
medium
inject
transplacent
one
side
cerebroventricular
spacelater
ventricl
lv
icr
mous
brain
inspect
day
later
describ
previous
wang
et
al
pregnant
dam
around
one
half
litterm
inject
zikv
cryosect
tissu
fix
pfa
dehydr
sucros
frozen
tfm
tissu
freez
medium
section
thick
use
immunofluoresc
stain
describ
previous
antibodi
use
immunostain
antizikv
serum
patient
abcam
phosphohiston
abcam
abcam
miilipor
neun
abcam
abcam
nuclei
stain
dapi
invitrogen
brain
slice
stain
toluidin
blue
min
dehydr
turn
ethanol
twice
final
slice
hyalin
xylen
min
seal
neutral
balsam
slice
imag
lsm
carl
zeiss
confoc
microscop
imag
analyz
qualifi
zen
blue
edit
imagej
describ
previous
prism
softwar
graphpad
use
analyz
data
data
shown
mean
sem
three
repeat
assay
p
p
p
unpair
student
ttest
ebov
entri
inhibitor
report
previous
johansen
et
al
johansen
et
al
kouznetsova
et
al
found
fdaapprov
drug
chloroquin
cq
clomiphen
amodiaquin
alverin
sertralin
could
inhibit
earli
stage
zikv
infect
fig
consist
fact
ribavirin
polymeras
inhibitor
disrupt
zikv
entri
experi
therefor
serv
neg
control
fig
sinc
clomiphen
given
safe
pregnant
women
legro
et
al
amodiaquin
alverin
sertralin
less
effect
inhibitor
focus
cq
efficaci
similar
known
zikv
entri
inhibitor
li
et
al
cq
zikv
recent
asian
lineag
strain
vero
cell
cell
fig
cytotox
induc
cq
even
fig
kouznetsova
et
al
cq
also
inhibit
zikv
strain
old
asian
lineag
cell
fig
order
detect
step
zikv
life
cycl
inhibit
cq
intern
assay
perform
previous
describ
talarico
et
al
use
rna
synthesi
intern
zikv
f
detect
use
plaqu
assay
qrtpcr
respect
g
zikv
replicon
rna
transfect
cell
h
later
cq
use
treat
cell
h
renilla
luciferas
activ
measur
micropl
reader
data
shown
mean
sem
three
independ
experi
p
p
p
unpair
student
ttest
inhibitor
neg
control
result
show
cq
suppress
zikv
intern
effect
fig
howev
cq
interfer
zikv
bind
cell
rna
synthesi
fig
g
next
test
abil
cq
protect
zikv
infect
vivo
weekold
immunocompet
balbc
mice
treat
cq
mgkg
intragastr
administr
ig
h
zikv
infect
intraperiton
ip
rout
strain
pfumous
cq
treatment
significantli
suppress
zikv
infect
mice
compar
pb
control
day
postinfect
dpi
fig
use
receptor
ifnar
defici
mous
model
dai
et
al
lazear
et
al
evalu
protect
effect
cq
zikv
infect
mice
treat
pb
cq
ig
mgkg
h
zikv
infect
strain
pfumous
daili
follow
day
viremia
measur
dpi
found
significantli
reduc
cqtreat
mice
fig
sinc
cq
transmit
breastmilk
found
inhibit
human
coronaviru
infect
newborn
mice
matern
milk
keyaert
et
al
test
effect
cq
zikv
infect
neonat
mous
model
fig
found
cq
treatment
mother
mice
could
improv
surviv
zikvinfect
suckl
neonat
mice
fig
cq
administr
hour
post
infect
hpi
protect
effect
reduc
becam
complet
absent
postpon
cq
treatment
hpi
result
show
cq
suppress
zikv
mous
infect
previous
shown
convalesc
serum
patient
recov
zikv
infect
protect
embryon
mice
zikv
infect
associ
microcephali
li
et
al
wang
et
al
adopt
model
investig
effect
cq
litterm
embryo
zikv
pfu
cultur
medium
inject
cerebroventricular
space
brain
embryon
day
icr
mice
pregnant
mice
treat
pb
veh
cq
ig
mgkg
h
infect
embryon
brain
day
mice
sacrif
inspect
first
investig
whether
cq
could
protect
mice
microcephali
caus
zikv
infect
compar
mockinfect
zikvinfect
cqtreat
group
averag
brain
size
zikvinfect
untreat
mice
significantli
smaller
fig
addit
brain
mice
significantli
thinner
cortex
compar
brain
uninfect
cqtreat
mice
fig
reduc
thick
differ
layer
cortex
confirm
immunostain
neun
antibodi
fig
fig
next
explor
whether
cq
treatment
could
suppress
zikv
infect
fetal
brain
immunostain
antizikv
serum
show
embryon
brain
infect
zikv
treat
cq
dramat
reduc
burden
zikv
compar
untreat
infect
brain
fig
similarli
intens
cell
posit
activ
form
caspas
indic
apoptosi
also
reduc
substanti
cq
treatment
fig
find
indic
cq
significantli
reduc
zikv
infect
associ
apoptot
effect
fetal
brain
shown
previous
contribut
factor
develop
microcephali
wang
et
al
infect
neuron
progenitor
cell
npc
dysregul
prolifer
differenti
may
also
contribut
thinner
vzsvz
cortic
layer
microcephali
wang
et
al
investig
whether
cq
could
prevent
effect
npc
prolifer
zikv
infect
shown
fig
cell
posit
phosphoryl
histon
marker
cell
mphase
significantli
reduc
zikvinfect
brain
surprisingli
cell
rescu
cq
therapi
similarli
reduct
npc
marker
intermediatebas
progenitor
cell
marker
cell
also
revers
treat
cq
fig
find
correl
chang
cortic
layer
thick
overal
size
zikvinfect
brain
therefor
cq
treatment
protect
embryon
mice
zikv
infect
associ
microcephali
recent
xu
et
al
perform
screen
compound
approv
investig
fda
found
could
suppress
zikv
infect
neural
cell
similarli
barrow
et
al
test
fdaapprov
drug
found
inhibitori
effect
zikv
replic
vitro
barrow
et
al
xu
et
al
howev
vivo
test
drug
yet
perform
chose
begin
screen
ebov
inhibitor
yield
much
higher
percentag
promis
zikv
therapeut
recent
bullardfeibelman
et
al
report
fdaapprov
antihepat
c
drug
sofobuvir
also
inhibit
zikv
infect
vitro
vivo
bullardfeibelman
et
al
howev
abil
prevent
zikvassoci
microcephali
remain
unclear
drug
also
expens
cq
wide
use
antimalari
drug
found
toxic
effect
pregnant
women
infant
previous
two
clinic
trial
investig
antivir
effect
cq
denv
infect
borg
et
al
tricou
et
al
patient
given
cq
day
begin
h
infect
denv
trial
result
show
cq
reduc
durat
viral
infect
could
reduc
chanc
dengu
hemorrhag
fever
tricou
et
al
well
decreas
patient
perceiv
intens
pain
improv
daili
activ
perform
borg
et
al
result
demonstr
cq
prevent
zikv
mgkg
cq
administr
mice
ig
h
zikv
infect
ip
pfumous
balbc
pfumous
experi
viremia
determin
bc
dpi
indic
improv
surviv
zikvinfect
suckl
neonat
mice
cq
given
breastfeed
mother
neonat
mice
infect
intracerebr
zikv
pfumous
strain
kunm
mother
mice
administr
cq
subcutan
sc
hpi
cq
continu
given
daili
mother
anoth
day
surviv
zikvinfect
neonat
mice
follow
dpi
median
valu
mice
experi
ac
shown
p
p
p
unpair
student
ttest
logrank
mantelcox
test
use
pb
n
hpi
n
hpi
n
hpi
n
induc
mortal
suckl
mice
administr
soon
infect
hpi
antivir
effect
administr
hpi
fig
togeth
find
provid
valuabl
inform
set
futur
clinic
trial
use
cq
zikv
infect
addit
widespread
avail
cq
well
safeti
profil
pregnanc
import
benefit
global
distribut
rnaseq
detect
induct
multipl
cytokin
embryon
brain
upon
zikv
infect
suggest
strong
immun
respons
like
play
import
role
neuron
cell
death
lead
microcephali
cq
may
protect
mice
zikvinduc
inflammatori
chang
critic
stage
brain
develop
although
would
need
investig
also
notic
investig
extens
use
cq
possibl
zikv
therapi
human
methodolog
restrict
screen
zikv
therapeut
fdaapprov
ebovinhibitor
effici
like
allow
promis
candid
like
cq
quickli
reach
clinic
trial
strategi
import
rapidli
bring
market
therapeut
could
help
prevent
reliev
symptom
zikv
infect
also
consid
emerg
infect
futur
fund
provid
role
perform
experi
write
manuscript
decis
submit
public
author
confirm
known
conflict
interest
associ
public
gc
zx
cfq
fxq
jointli
direct
research
cl
xz
design
perform
experi
analyz
data
fig
cq
protect
embryon
brain
zikv
infect
microcephali
litterm
embryon
brain
inject
zikv
medium
pregnant
mice
treat
daili
cq
vehicl
imag
brain
nissl
stain
coron
section
b
measur
cortic
layer
thick
mock
veh
n
mock
cq
n
zikv
veh
n
zikv
cq
n
cp
cortic
plate
sp
subplat
iz
intermedi
zone
svz
subventricular
zone
vz
ventricular
zone
c
imag
coron
section
stain
zikv
antiserum
green
dapi
blue
right
panel
quantif
rel
intens
n
imag
cortic
stain
activ
form
white
dapi
blue
right
panel
quantif
rel
intens
n
e
imag
cortic
stain
phosphoryl
histon
red
right
panel
quantif
cell
mock
veh
n
mock
cq
n
zikv
veh
n
zikv
cq
n
f
coron
section
stain
zikv
green
red
white
right
panel
quantif
densiti
cell
cell
cortic
mock
veh
n
mock
cq
n
zikv
veh
n
zikv
cq
n
data
mean
sem
student
ttest
p
b
p
b
p
b
p
b
p
b
p
b
ns
signific
n
number
slicesdiffer
brain
scale
bar
mm
bf
wrote
first
draft
manuscript
xj
help
perform
mice
relat
experi
nq
yqd
mt
ra
xz
ly
ska
xfl
juj
kn
help
perform
experi
revis
manuscript
contribut
reagent
